| Change Notification | Applies to: * | Date | ||||||
|---|---|---|---|---|---|---|---|---|
| BM-DSG | CB-DSG | GDRI | TD-DSG | TL-DSG | WB-DSG | Red Book | ||
| No. 74 - 2020 COVID-19 Vaccine |
⬤ | ⬤ | ⬤ | ⬤ | 15.12.20 | |||
| No. 73 - 2020 COVID-19 Vaccine |
⬤ | 15.12.20 | ||||||
| No. 67 - 2020 Convalescent Plasma (COVID-19), FFP, for Neonates and Infants, Leucocyte Depleted |
⬤ | 17.11.20 | ||||||
| No. 66 - 2020 Convalescent Plasma (COVID-19), FFP, Leucocyte Depleted |
⬤ | 17.11.20 | ||||||
| No. 65 - 2020 Clinical Trials |
⬤ | 13.11.20 | ||||||
| No. 64 - 2020 Coronavirus Infection |
⬤ | 13.11.20 | ||||||
| No. 63 - 2020 Netherlands |
⬤ | 10.11.20 | ||||||
| No. 62 - 2020 Netherlands |
⬤ | 20.10.20 | ||||||
| No. 61 - 2020 Sexually Transmitted Disease |
⬤ | ⬤ | ⬤ | ⬤ | 07.10.20 | |||
| No. 60 - 2020 Spain |
⬤ | 21.09.20 | ||||||
| No. 50 - 2020 Germany |
⬤ | 15.09.20 | ||||||
| No. 49 - 2020 Spain |
⬤ | 18.08.20 | ||||||
| No. 48 - 2020 Transfusion |
⬤ | 21.09.20 | ||||||
| No. 47 - 2020 Platelets, Apheresis, Leucocyte Depleted, at Reduced Dose as a Contingency |
⬤ | 16.09.20 | ||||||
| No. 46 - 2020 Systemic Lupus Erythematosus |
⬤ | ⬤ | &nsbp; | 07.10.20 | ||||
| No. 45 - 2020 Transfusion |
⬤ | ⬤ | ⬤ | 07.10.20 | ||||
| No. 44 - 2020 South American Trypanosomiasis Risk |
⬤ | ⬤ | ⬤ | ⬤ | 07.10.20 | |||
| No. 43 - 2020 Infection - Chronic |
⬤ | ⬤ | ⬤ | ⬤ | 07.10.20 | |||
| No. 42 - 2020 Tamoxifen |
⬤ | ⬤ | ⬤ | ⬤ | 07.10.20 | |||
| No. 41 - 2020 Infection - Acute |
⬤ | ⬤ | ⬤ | 15.07.20 | ||||
| No. 40 - 2020 Tamiflu® and Relenza® |
⬤ | ⬤ | ⬤ | ⬤ | 15.07.20 | |||
| No. 39 - 2020 Infection - Acute |
⬤ | 15.07.20 | ||||||
| No. 38 - 2020 Viral Haemorrhagic Fever |
⬤ | ⬤ | ⬤ | ⬤ | 15.07.20 | |||
| No. 37 - 2020 Rabies |
⬤ | ⬤ | ⬤ | ⬤ | 15.07.20 | |||
| No. 36 - 2020 Animal Bite |
⬤ | ⬤ | ⬤ | ⬤ | 15.07.20 | |||
| No. 35 - 2020 Whole Blood, Leucocyte Depleted for Clinical Studies |
⬤ | 26.10.20 | ||||||
| No. 33 - 2020 Coronavirus Infection |
⬤ | 24.06.20 | ||||||
| No. 32 - 2020 Red Cells and Plasma, Leucocyte Depleted |
⬤ | 08.06.20 | ||||||
| No. 31 - 2020 Coronavirus Infection |
⬤ | ⬤ | 08.06.20 | |||||
| No. 30 - 2020 Coronavirus Infection |
⬤ | 08.06.20 | ||||||
| No. 29 - 2020 Coronavirus Infection |
⬤ | 08.06.20 | ||||||
| No. 28 - 2020 Northern Ireland - Donor selection changes 2020 |
⬤ | 01.06.20 | ||||||
| No. 27 - 2020 Chapter 3 |
⬤ | 07.05.20 | ||||||
| No. 26 - 2020 Haemoglobin Estimation |
⬤ | 07.05.20 | ||||||
| No. 25 - 2020 Fresh Frozen Plasma, Leucocyte Depleted |
⬤ | 06.05.20 | ||||||
| No. 24 - 2020 Cryoprecipitate for Neonates and Infants, Leucocyte Depleted |
⬤ | 06.05.20 | ||||||
| No. 23 - 2020 Fresh Frozen Plasma for Neonates and Infants, Leucocyte Depleted |
⬤ | 06.05.20 | ||||||
| No. 22 - 2020 Red Cells in Additive Solution, Leucocyte Depleted, Extended Shelf Life |
⬤ | 21.04.20 | ||||||
| No. 21 - 2020 Annexe 5: Blood Components for Contingency Use |
⬤ | 21.04.20 | ||||||
| No. 20 - 2020 Granulocytes, Apheresis |
⬤ | 21.04.20 | ||||||
| No. 19 - 2020 Annexe 4: Redundant Components |
⬤ | 21.04.20 | ||||||
| No. 17 - 2020 Coronavirus Infection |
⬤ | ⬤ | 23.03.20 | |||||
| No. 16 - 2020 Coronavirus Infection |
⬤ | 23.03.20 | ||||||
| No. 15 - 2020 Coronavirus Infection |
⬤ | 23.03.20 | ||||||
| No. 14 - 2020 Coronavirus Risk and Airport Stopovers |
⬤ | 20.03.20 | ||||||
| No. 13 - 2020 Coronavirus Infection |
⬤ | 18.03.20 | ||||||
| No. 12 - 2020 Italy |
⬤ | 09.03.20 | ||||||
| No. 11 - 2020 Coronavirus Risk |
⬤ | 26.02.20 | ||||||
| No. 10 - 2020 Coronavirus Infection |
⬤ | ⬤ | ⬤ | ⬤ | 24.02.20 | |||
| No. 09 - 2020 Coronavirus Infection |
⬤ | 24.02.20 | ||||||
| No. 08 - 2020 Coronavirus Infection |
⬤ | ⬤ | ⬤ | ⬤ | ⬤ | 17.20.20 | ||
| No. 07 - 2020 Coronavirus Risk |
⬤ | 17.02.20 | ||||||
| No. 06 - 2020 Coronavirus Risk |
⬤ | 07.02.20 | ||||||
| No. 05 - 2020 Coronavirus Infection |
⬤ | ⬤ | ⬤ | ⬤ | 23.01.20 | |||
| No. 04 - 2020 China |
⬤ | |||||||
| No. 03 - 2020 Coronavirus Infection |
⬤ | 23.02.20 | ||||||
(*)
BM-DSG - Bone Marrow and Peripheral Blood Stem Cell Donor Selection Guidelines
CB-DSG - Cord Blood Donor Selection Guidelines
GDRI - Geographical Disease Risk Index
TD-DSG - Tissue (Deceased) Donor Selection Guidelines
TL-DSG - Tissue (Live) Donor Selection Guidelines
WB-DSG - Whole Blood and Components Donor Selection Guidelines
Red Book - Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK